comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 06:03:10 - browse：4

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Acelyrin, a rare IPO success, stumbles in its first big test

Pig kidney works a record two months in donated body

Hospitals consider fixing cancer drug shortages on their own

Regeneron agrees to White House price limits on anti

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Report captures long Covid’s disabling effects and policy challenges

hotspot

comprehensive

Sponsor introduction

Featured speakers

Sponsored By

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Food makers tried to stack nutrition panel with preferred experts

Dobbs anniversary: the lost opportunity of abortion as health care

ALS patient reclaims some autonomy thanks to wearable 'robot'

Hepatitis C has a cure — but many Americans still lack access to it

Walmart eyes Medicare Advantage provider ChenMed

Continuity nursing helped my family in our darkest PICU moments

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Trump demands the U.S. pay no more for drugs than other countries … again

Telehealth for opioid use disorder is lifesaving

leisure time

Cigna wins case to block Amy Bricker's move to CVS

Will the IRA bring competition to the biologics market?

New Covid vaccine is recommended for everyone 6 months or older

Lilly's Alzheimer's drug donanemab backed by FDA advisers

New Covid vaccine is recommended for everyone 6 months or older

Hospitals consider fixing cancer drug shortages on their own

hotspot

entertainment

explore

entertainment